ReviewTranslating cognition from animals to humans
Graphical abstract
Introduction
Translational neuroscience has now become crucial to drug discovery. The vast expense of Phase 3 trials and relative lack of success of developing effective new compounds in psychiatry has necessitated a new approach to the use of animal models and preclinical strategies. Some of this lack of success is attributable to the lack of reporting of failed clinical studies which would allow more rigorous analysis and comparison across the human and animal data. Concern has also been raised relating to the short-comings of animal models, with a failure to robustly guide the use of new compounds in the clinic, although we would suggest that there may also have been deficiencies in implementation and interpretation of the animal models themselves. Thus, for example, pragmatic requirements have often resulted in the use of less rigorous procedures or a reliance on only a single behavioral assay. Moreover, we find insufficient evidence of ‘back-translation’ (from humans to animals) of the fate of new drugs for us to be confident that any ‘failures’ are necessarily a result of inadequate animal models. Nevertheless, we believe that the new emphasis on translation has brought focus onto ‘construct validity’—whether the identified cognitive processes are adequately homologous between species. This is distinct from ‘predictive validity’ which remains useful for predicting, for example whether a drug has an anti-depressant like action, but will too often result in another ‘me-too’ compound with the same basic failings as its relatives [1]. Clearly it is important to be sure that the predictive validity does not merely identify compounds that produce a particular effect if that effect is not convincingly linked to therapeutic benefit [2]. Additionally, progress in genetics and developmental biology has resulted in emphasis on the use of transgenic techniques as a new approach to understanding the aetiology of neuropsychiatric disorders and the identification of endophenotypes [3].
Section snippets
Test batteries for cognitive disorders
There are now an overwhelming number of clinical disorders requiring treatment of cognitive dysfunction, including not only obvious examples such as Alzheimer's disease, but also other neurodegenerative conditions such as Parkinson's and Huntington's disease, brain damage resulting from stroke or other injury, schizophrenia and bipolar disorder, depression, the sequelae of addiction, and developmental disorders such as autism and attention deficit hyperactivity disorder. It is important to
Perception
Perception is the ‘on-line’ representation of the world by the sensory systems and must ultimately be used to make decisions. This percept of the world is the result of current sensory stimulation which is temporally bound together over transient time- and space-windows and combined with longer term memory systems. Perception is generally tested in experimental animals and humans by means of discrimination learning and recognition, whereby responding in the presence of one stimulus is
Conclusions
In this survey, we have mainly discussed how it is feasible to model specific aspects of cognition in experimental animals that may bear some approximation to the greater complexity often observed in human patients. As cognition is not a unitary construct, it is necessary to focus on specific aspects, for example, of memory that are highlighted by the patient's deficits. It is often important to test cognition in humans and other animals in ways that are as similar as possible, for example,
Acknowledgements
This work has received funding from the Innovative Medicines Initiative (IMI) Joint Undertaking under grant agreement no. 115008. IMI is a public–private partnership between the European Union and the European Federation of Pharmaceutical Industries and Associations. This work was carried out at The Behavioral and Clinical Neuroscience Institute (BCNI), a joint award from the Medical Research Council (MRC) and Wellcome Trust (G0001354) to Prof TW Robbins (Director) and Prof ET Bullmore
References (96)
- et al.
Identification of separable cognitive factors in schizophrenia
Schizophrenia Research
(2004) - et al.
Set-shifting ability and schizophrenia: a marker of clinical illness or an intermediate phenotype
Biological Psychiatry
(2008) - et al.
Behavioural despair in rats: a new model sensitive to antidepressant treatments
European Journal of Pharmacology
(1978) - et al.
A new one-trial test for neurobiological studies of memory in rats. 1: behavioral data
Behavioural Brain Research
(1988) - et al.
The pharmacology, neuroanatomy and neurogenetics of one-trial object recognition in rodents
Neuroscience & Biobehavioral Reviews
(2007) - et al.
Visuo-spatial short-term recognition memory and learning after temporal lobe excisions, frontal lobe excisions or amygdalo-hippocampectomy in man
Neuropsychologia
(1995) - et al.
Spatial memory and hippocampal function
Neuropsychologia
(1979) - et al.
Humans with hippocampus damage display severe spatial memory impairments in a virtual Morris water task
Behavioural Brain Research
(2002) - et al.
Anomalous neural circuit function in schizophrenia during a virtual Morris water task
NeuroImage
(2010) - et al.
Wistar rats show episodic-like memory for unique experiences
Neurobiology of Learning and Memory
(2006)
Lesions of the medial prefrontal cortex or nucleus accumbens core do not impair inhibitory control in rats performing a stop-signal reaction time task
Behavioural Brain Research
Effect of disconnecting the orbital prefrontal cortex from the nucleus accumbens core on inter-temporal choice behaviour: a quantitative analysis
Behavioural Brain Research
Drug addiction endophenotypes: impulsive versus sensation-seeking personality traits
Biological Psychiatry
Orbital prefrontal cortex mediates reversal learning and not attentional set shifting in the rat
Behavioural Brain Research
Removing obstacles in neuroscience drug discovery: the future path for animal models
Neuropsychopharmacology
Challenges in the search for drugs to treat central nervous system disorders
Journal of Pharmacology and Experimental Therapeutics
The endophenotype concept in psychiatry: etymology and strategic intentions
American Journal of Psychiatry
Cambridge Neuropsychological Test Automated Battery (CANTAB): a factor analytic study of a large sample of normal elderly volunteers
Dementia
A study of performance on tests from the CANTAB battery sensitive to frontal lobe dysfunction in a large sample of normal volunteers: implications for theories of executive functioning and cognitive aging
Journal of the International Neuropsychological Society
Effects of fornix transection upon associative memory in monkeys: role of the hippocampus in learned action
The Quarterly Journal of Experimental Psychology Section B: Comparative and Physiological Psychology
A novel automated touchscreen procedure for assessing learning in the rat using computer graphic stimuli
Neuroscience Research Communications
The behavior of the laboratory rat: a handbook with tests (Part VII)
Intracranial self-stimulation thresholds as a measure of reward
Behavioural Neuroscience: A Practical Approach
Visual perception and memory: a new view of medial temporal lobe function in primates and rodents
Annual Reviews in Neuroscience
A functional role for adult hippocampal neurogenesis in spatial pattern separation
Science
Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review
Psychopharmacology (Berl.)
The attention system of the human brain
Annual Review of Neuroscience
Covert orienting of attention in the rat and the role of striatal dopamine
Journal of Neuroscience
The “two-headed” latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment
Psychopharmacology
The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry
Psychopharmacology (Berl.)
Enhanced and impaired attentional performance after infusion of D1 dopaminergic receptor agents into rat prefrontal cortex
Journal of Neuroscience
Further analysis of the cognitive effects of tetrahydroaminoacridine (THA) in Alzheimer's disease: assessment of attentional and mnemonic function using CANTAB
Psychopharmacology
Depletion of unilateral striatal dopamine impairs initiation of contralateral actions and not sensory attention
Nature
Crossmodal divided attention in rats: effects of chlordiazepoxide and scopolamine
Psychopharmacology
Dissociation in prefrontal cortex of affective and attentional shifts
Nature
Fractionating attentional control using event-related fMRI
Cerebral Cortex
Medial frontal cortex mediates perceptual attentional set shifting in the rat
Journal of Neuroscience
Multiple dopamine receptor subtypes in the medial prefrontal cortex of the rat regulate set-shifting
Neuropsychopharmacology
Rule learning and reward contingency are associated with dissociable patterns of dopamine activation in the rat prefrontal cortex, nucleus accumbens, and dorsal striatum
Journal of Neuroscience
The neuropsychiatry of impulsivity
Current Opinion in Psychiatry
Modafinil improves cognition and attentional set shifting in patients with chronic schizophrenia
Neuropsychopharmacology
Comparison of haloperidol, risperidone, sertindole, and modafinil to reverse an attentional set-shifting impairment following subchronic PCP administration in the rat—a back translational study
Psychopharmacology
Conditioning and associative learning
Neuronal coding of prediction errors
Annual Reviews in Neuroscience
Disrupted prediction-error signal in psychosis: evidence for an associative account of delusions
Brain
Medial prefrontal cortex determines how stressor controllability affects behavior and dorsal raphe nucleus
Nature Neuroscience
The tail suspension test: a new method for screening antidepressants in mice
Psychopharmacology
Cited by (113)
Assessment of lisdexamfetamine on executive function in rats: A translational cognitive research
2024, Experimental NeurologyExecutive dysfunction and cognitive decline, a non-motor symptom of Parkinson's disease captured in animal models
2024, International Review of NeurobiologyPossible effects of pair bonds on general cognition: Evidence from shared roles of dopamine
2023, Neuroscience and Biobehavioral ReviewsSalt as a non-caloric behavioral modifier: A review of evidence from pre-clinical studies
2022, Neuroscience and Biobehavioral ReviewsA review of behavioral methods for the evaluation of cognitive performance in animal models: Current techniques and links to human cognition
2022, Physiology and BehaviorCitation Excerpt :This gap is demonstrated by key differences in cognitive abilities and the claim that humans have unique cognitive abilities. The challenge is to identify the cognitive systems that are shared between animals and humans and determine how they work together [53, 54]. There are recent studies that indicate animals have similar cognitive abilities, such as episodic memory, non-linguistic mathematical ability, and the capacity to navigate landmarks [54, 55].